Related resources
Full-text held externally
- PMID: 23577876
- UKPMCID: 23577876
- DOI: 10.1111/jce.12142
Search for item elsewhere
University researcher(s)
Academic department(s)
Advantages of a Subcutaneous Implantable Cardioverter-Defibrillator in LAMP2 Hypertrophic Cardiomyopathy.
Zaki, Aly; Zaidi, Amir; Newman, William G; Garratt, Clifford J
Journal of cardiovascular electrophysiology. 2013;.
Access to files
Full-text and supplementary files are not available from Manchester eScholar. Full-text is available externally using the following links:
Full-text held externally
- PMID: 23577876
- UKPMCID: 23577876
- DOI: 10.1111/jce.12142
Abstract
Danon disease is a rare X-linked lysosomal disease causing severe hypertrophic cardiomyopathy (LAMP2 cardiomyopathy) and an extremely poor prognosis in males, with several reported cases of sudden cardiac death despite the use of transvenous implantable cardioverter defibrillators (TV-ICD). We describe a case in which a TV-ICD was unable to defibrillate induced ventricular fibrillation (VF), but a wholly subcutaneous system (S-ICD) was successful in terminating induced VF and spontaneous ventricular tachycardia. These findings have relevance to the selection of device therapy in the management of these individuals and a wider group of young patients with severe hypertrophic cardiomyopathy.